Plant viruses are generally considered incapable of infecting vertebrates. Accordingly, they are not considered harmful for humans. However, a few studies questioned the certainty of this paradigm. Tobacco mosaic virus (TMV) RNA has been detected in human samples and TMV RNA translation has been described in animal cells. We sought to determine if TMV is detectable, persists, and remains viable in the lung tissues of mice following intratracheal inoculation, and we attempted to inoculate mouse macrophages with TMV. In the animal model, mice were intratracheally inoculated with 1011 viral particles and were sacrificed at different time points. The virus was detected in the mouse lungs using immunohistochemistry, electron microscopy, real-time RT-PCR and sequencing, and its viability was studied with an infectivity assay on plants. In the cellular model, the culture medium of murine bone marrow derived macrophages (BMDM) was inoculated with different concentrations of TMV, and the virus was detected with real-time RT-PCR and immunofluorescence. In addition, anti-TMV antibodies were detected in mouse sera with ELISA. We showed that infectious TMV could enter and persist in mouse lungs via the intratracheal route. Over 14 days, the TMV RNA level decreased by 5 log10 copies/ml in the mouse lungs and by 3.5 log10 in macrophages recovered from bronchoalveolar lavage. TMV was localized to lung tissue, and its infectivity was observed on plants until 3 days after inoculation. In addition, anti-TMV antibody seroconversions were observed in the sera from mice 7 days after inoculation. In the cellular model, we observed that TMV persisted over 15 days after inoculation and it was visualized in the cytoplasm of the BMDM. This work shows that a plant virus, Tobacco mosaic virus, could persist and enter in cells in mammals, which raises questions about the potential interactions between TMV and human hosts.
Citation: Balique F, Colson P, Barry AO, Nappez C, Ferretti A, Moussawi KA, et al. (2013) Tobacco Mosaic Virus in the Lungs of Mice following Intra-Tracheal Inoculation. PLoS ONE 8(1): e54993. https://doi.org/10.1371/journal.pone.0054993
Editor: Robert Shin Fujinami, University of Utah School of Medicine, United States of America
Received: July 9, 2012; Accepted: December 19, 2012; Published: January 30, 2013
Copyright: © 2013 Balique et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: Recurrent funding from the Centre National de la Recherche Scientifique (CNRS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Competing interests: The authors have declared that no competing interests exist.
Plant viruses are abundant inhabitants of the biosphere and are responsible for major diseases in a wide range of crops worldwide . Their host repertoire is not known to overlap with that of vertebrate viruses, which suggests that the viruses of Plantae and Vertebrata exist as infectious members of two separate worlds. Accordingly, plant viruses are not considered harmful for humans. An example of the confidence in this dogma comes from new prospects in the field of vaccine immunization that use plant virus-based vaccines , .
Tobamoviruses are known for their extraordinary resistance to heat, desiccation, freezing and thawing . The archetypal Tobacco mosaic virus (TMV) is considered to be extraordinarily stable and is the most heat-resistant plant pathogen known , . TMV remained identifiable by electron microscopy after a storage of 50 years . TMV has a single-stranded RNA genome of 6,400 nucleotides and was recently classified in the Virgaviridae family . This rod-shaped virus infects tobacco plants and causes mottling and discoloration of leaves. The abundance of biological data accumulated for TMV , its high replication rate in plants, and the dogma that TMV, as other plant viruses, is safe for vertebrate animals including humans, led researchers to consider this virus as a good candidate for new experimental vaccine strategies , , –. Indeed, TMV-derived recombinant vaccines can facilitate the exposure of vertebrates to various peptides.
However, TMV RNA entry and translation have been described in oocytes of Xenopus laevis, in mouse liver mitochondria and possibly in rabbit reticulocytes –. In addition, TMV capsid protein has been translated in HeLa cells in which TMV RNA was demonstrated to trigger autophagy, and intracellular TMV-resembling particles were reported by electron microscopy . Moreover, several teams reported the presence of TMV in non-human and human vertebrates. Erickson et al. described in 1953 the persistence of TMV in extracts of mouse livers 9 days after intravenous inoculation with a 2 mg dose of TMV by means of precipitation with anti-TMV antibodies, and 15 days post-injection by electron microscopy . The same team demonstrated in 1957 the intracellular localization of TMV in the mouse liver . Later, in the 1960s, Bothwell raised the issue of a possible causal relationship between TMV and lung cancer , and TMV has been cultured from the sputum and thoracentesis fluids of cigarette smokers with a history of pulmonary disease, including lung cancer , . Finally, very recently, TMV RNA was recovered by two different teams using metagenomics in the feces of non-diarrheic and diarrheic persons , . The clinical significance of these findings is unresolved. Detecting TMV in human feces is reasonable as we may ingest TMV particles through eating TMV-infected vegetables, e.g., peppers or tomatoes. Tobacco cigarette smoking may be another major source of exposure to TMV. Indeed, according to the world health organization, more than 15 billion cigarettes are smoked worldwide daily (http://www.who.int/tobacco/en/atlas8.pdf) and TMV is known to be present and stable in the tobacco of cigarettes and cigars , , , . We recently detected TMV RNA in all 47 smoking cigarettes of six brands, mean titer being 9.5 log10 copies/cigarette . In addition, TMV was found viable in 53% of these cigarettes as shown by the development of local lesions on leaves of Nicotiana tabacum Xanthi (NtX) after inoculation. Moreover, we detected TMV RNA in 45% of the 44 saliva from 12 smokers while in none of the 16 saliva from 15 non-smokers (p = 0.001), which indicated that the TMV genome may get access to the human body through smoking. Interestingly, Bousbia et al. recently reported the protracted detection of plant DNA, including Nicotiana tabacum chloroplast DNA, in the bronchoalveolar lavage fluid of mechanically ventilated pneumonia patients, which suggests that TMV may be conveyed to the lungs in tobacco . To better understand the interactions between TMV and humans, we sought to determine if TMV is detectable, persists, and remains viable in the lung tissues of vertebrate animals following inoculation. For this purpose, we used an experimental mouse model consisting of intratracheal inoculation of the virus. In addition, we attempted to infect mouse macrophages with TMV.
TMV Localization in Mouse Lungs
At different times after intratracheal inoculation, TMV-inoculated and control mice were sacrificed and their lungs were collected. Inflammatory reactions to TMV were observed in lungs of all three inoculated mice at day 3 after intra-tracheal inoculation, whereas no histological changes were found in the two control mice at different times and in other TMV-inoculated mice at day 1, 7 and 14 after the virus inoculation (Figure 1). In TMV-inoculated mice at day 3, inflammatory infiltrates without necrotic damage were confined within the alveolar walls. The interalveolar walls were infiltrated by mononuclear inflammatory cells composed mainly of macrophages without granulomatous organization. The bronchoalveolar air spaces were relatively free of cellular exudates. TMV antigens were detected by immunohistochemistry in the lungs of one TMV-inoculated mouse at day 1 and in two mice at day 3 after inoculation whereas not in control mice and in TMV-inoculated mice at days 7 and 14 post-inoculation (Figure 2). Immunopositive material was observed in the cytoplasm of cells that had macrophage morphology.
Note the absence of inflammation in the lungs of control mice, whereas inflammatory infiltrates in interalveolar walls composed in part by macrophages were observed in lungs from TMV-inoculated mice. Hematoxylin-eosin staining was used. Magnification, 200X (A and B) and 400X (C and D). Arrows indicate the inter-alveolar walls inflammation.
No immunodetection was observed in lung from a water-inoculated mouse (A), whereas cytoplasmically immunopositive cells located in inflammatory infiltrates present in interalveolar walls, most likely macrophages, were detected at day 1 (B) and day 3 (C) after intratracheal inoculation. Polyclonal rabbit anti-TMV antibody was used at a dilution of 1∶500, with hemaxylin counterstain. Magnification, 400X. Arrows show macrophages positive for TMV antigen detection.
Anti-TMV total antibodies were concurrently tested in serum samples from TMV-inoculated mice and control mice immediately before the intratracheal inoculation and 7 and 14 days after inoculation (Figure 3). For TMV-inoculated mice, the mean optical density (OD) was 0.04±0.03 at day 0, 0.42±0.23 at day 7 and 0.32±0.21 at day 14 post-inoculation. The mean OD increase between day 0 and day 7 was statistically significant (p = 0.0001). In contrast, for serum samples from control mice, the mean OD was 0.03±0.01 at day 0, 0.09±0.05 at day 7 and 0.14±0.04 at day 14 post-inoculation. Furthermore, we found a statistically significant difference between mean OD for sera collected from TMV-inoculated and control mice 7 days after TMV inoculation (p = 0.0024). Finally, taking into account longitudinal serum samples from ten different mice in the same experiment, seroconversion was observed in 6 TMV-inoculated mice on day 7, based on an OD greater than the mean value at baseline plus 10 SD , .
Detection of anti-TMV total antibodies in serum samples of 10 TMV-inoculated and 5 control mice at day 0 (just before the operation), and 13 TMV-inoculated and 8 control mice at day 7 and day 14 after intratracheal inoculation. *Statistically significant.
Detection, Quantification and Viability of TMV in Mice Samples
After mouse sacrifice, a sample of lung tissue was crushed for RNA extraction, and TMV RNA was quantified by real-time RT-PCR targeting the coat protein and replicase genes (Table 1). TMV RNA was detected by two real-time RT-PCR assays in the lungs of all 21 TMV-inoculated mice from day 1 until 14 days after TMV inoculation. In contrast, no TMV RNA was detected in the 11 samples from control mice. The mean TMV RNA level assessed in lungs from TMV-inoculated mice with the system targeting the coat protein was 9.87±3.48 log10 copies/ml one day after TMV inoculation, 7.5±6.9 log10 at day 2, 8.2±7.2 log10 at day 3, 8.0±4.5 log10 at day 7, 4.3±3.4 log10 at day 12 and 4.8±4.8 log10 at day 14 (Figure 4). Similar results were obtained using the real-time PCR system for the replicase gene. Indeed, the TMV RNA level was 10.2±1.1 log10 copies/ml one day after TMV inoculation, 8.3±1.7 log10 at day2, 8.5±2.2 log10 at day3, 7.9±2.3 log10 at day 7, 5.9±0.3 log10 at day12 and 5.1±1.7 log10 at day14 (Figure 4). Thus, in 14 days, the TMV RNA level decreased by approximately 5 log10 in mouse lung homogenates. In addition, all lung samples were tested by conventional RT-PCR for the helicase gene or the protein movement gene (Table 1). In 20 of 21 lung samples of TMV-inoculated mice, TMV RNA was identified by population sequencing. Additionally, rod shape TMV-resembling particles could be visualized by electron microscopy in 7 lung homogenate samples of 17 TMV-inoculated mice; two lung samples were observed positives at day 1, one at day 2, two at day 3 and two at day 7 after TMV inoculation (Figure 5).
A: TMV coat protein gene system; B: TMV replicase gene system. Control, non-inoculated mice.
Arrows indicate TMV-like particles.
The infectivity of the TMV present in lung tissue was tested for lung samples found positive in real-time RT-PCR on hypersensitive and susceptible host plants. Necrotic local lesions were obtained on three leaves of Nicotiana tabacum Xanthi for three lung samples from mice inoculated with TMV including mouse no. 2 at day 1 (five local lesions), mouse no. 1 at day 3 (more than 50 local lesions) and mouse no. 3 at day 3 (one lesion). A mosaic was also obtained on Nicotiana benthamiana for TMV-inoculated mouse no. 1 at day 3 (Figure 6). Overall, from the 21 samples from TMV-inoculated mice tested by real-time RT-PCR, 3 (14%) induced local necrotic lesions on Nicotiana tabacum Xanthi, and one of them induced systemic infection in a susceptible plant host. Lung samples harvested at day 7 and day 14 were not infectious for host plants. In addition, mechanical inoculation with lung samples from control mice did not induce any signs in plants (Figure 7).
A: Leaves of a non-inoculated plant; B: Leaves of a plant inoculated with a TMV RNA positive sample (TMV-inoculated mouse number 1 at day 3). Arrows show signs of systemic infection with discoloration and deformation of young leaves.
A: Leaf of a non-inoculated plant; B: Leaf of a plant inoculated with a TMV RNA positive sample (TMV-inoculated mouse number 2 at day1); C: Leaf of a plant inoculated with a TMV RNA positive sample (TMV-inoculated mouse number 1 at day 3). On inoculated leaves, arrows show local necrotic lesions induced by the virus in the plant cells.
Bronchoalveolar fluid samples (BAL).
BAL was performed in the second experiment on mice, immediately before the mice were sacrificed, and bronchial macrophages were isolated after two washings in RPMI with 10% fetal bovine serum (FBS). Washing supernatants, culture medium and macrophages from the BAL samples recovered from 10 TMV-inoculated mice and 5 control mice were tested by real-time RT-PCR. TMV RNA was detected in all of the samples from TMV-inoculated mice. TMV RNA titers in the BAL macrophages from TMV-inoculated mice were 8.7±0.4 log10 copies/ml two days post-viral inoculation, 7.4±1.6 log10 at day 7, 5.7±0.2 and 5.1 log10 at days 12 and 14 post-inoculation, respectively. Thus, the TMV RNA level decreased by 3.5 log10 in bronchial macrophages between days 2 and 14 post-infection (Figure 8). TMV helicase-encoding gene sequences were obtained from all BAL macrophage samples at day 2, 7, 12 and 14 after intratracheal TMV inoculation.
Localization, Detection and Quantification of TMV in Bone Marrow Derived Macrophages (BMDM)
To further study the TMV entry into murine macrophages, we inoculated BMDM with the virus. Four hours, 1, 3, 7 and 14 days after TMV inoculation in culture medium, cells were thoroughly washed and then fixed for immunofluorescence assays. Using mouse monoclonal anti-TMV antibodies, viral antigens were localized in the cytoplasm of TMV-inoculated macrophages and were not found in non-inoculated cells (Figure 9). To assess viral persistence in murine macrophages, TMV was detected in media and in washed BMDM cells during 15 days after inoculation (Figure 10). No difference between the viability of virus-inoculated and non-inoculated cells was observed throughout the experiment at each time point as assessed by optical microscopy of the cell monolayer. In the culture media, for the three tested quantities of virus, TMV RNA titers decreased from day 0 to day 15 after inoculation. Titers decreased by 6.4 log10 for 1011 particles per well, by 6.8 log10 for 109 particles per well, and by 3.2 log10 for 107 particles per well. No TMV RNA was detected in non-inoculated samples. In the washed BMDM cells, TMV RNA was detected in inoculated cells, and the titer also decreased over time. Titers decreased by 3.8 log10 in BMDM cells for 1011 particles per well, by 2.2 log10 for 109 particles per well, and at day 15 post-inoculation, TMV RNA was not detected in BMDM cells for 107 particles per well. The non-inoculated BMDM control cells all tested negative for the presence of TMV RNA.
BMDM were observed at day 1 (A and B), day 7 (C and D) and 14 (E and F) after inoculation with TMV. Non-inoculated cells (A, C, E) and TMV-inoculated cells (B, D, E) were analyzed using a mouse monoclonal anti-TMV antibody diluted at 1∶25 with goat anti-mouse 555 antibodies (red). Actin is stained with phallacidin-488 (green) and nuclei are stained with DAPI (blue). Arrows show TMV antigen (red) detected in BMDM cytoplasm. BMDM were observed by confocal microscopy with an oil immersion objective of 63X and a digital zoom of 2.
In this study, we showed that TMV could enter and persist in the lungs of intratracheally inoculated mice. We found TMV RNA at high titers using real-time RT-PCR in lung tissues and bronchoalveolar fluids, with RNA loads greater than 7 log10 copies/ml on days 2 and 7 post-inoculation, and we showed viral persistence for up to 14 days after inoculation, at which time the last mice were sacrificed. In addition, TMV-like particles were observed with electron microscopy, and immunohistochemical analysis indicated the presence of TMV in the mouse lungs. Notably, viruses could be localized within macrophages of the pulmonary tissue. Moreover, TMV remained infectious for its plant host up to 3 days post-inoculation. Finally, TMV-specific antibodies were detected in the sera of most inoculated mice. In addition, our cellular model using BMDM confirmed that TMV could be found inside animal cells, suggesting that TMV might be internalized by macrophages. We showed that TMV was localized in the cytoplasm of murine macrophages and persisted until 15 days after infection.
Although we did not evidence TMV replication in mouse lungs or murine macrophages in the present work, our findings raise concerns about the potential interactions between TMV and human hosts. There is other published literature that challenges the dogma of the strict boundaries between plants and vertebrates for viruses. In non-vertebrate animals, it was shown that plant pathogenic viruses displayed complex interactions with insects, and the transcription and replication of some plant viruses within insects was described –. In addition, in some cases, insects were found to be affected by plant viruses . Furthermore, it was recently shown that Tomato spotted wilt virus (TSWV) could infect two human cell lines, HeLa and diploid fibroblasts, depending on the expression of a viral polymerase-bound host factor . Additionally, despite plant virus replication was not observed in animals, Cowpea mosaic virus (CPMV), a plant comovirus in the picornavirus superfamily, was able to bind and enter mammalian cells, including endothelial cells, and the binding protein for the virus was identified as a cell-surface form of the intermediate filament vimentin . Furthermore, CPMV was found to persist for several days post oral or intravenous inoculation in a wide panel of body tissues in mice, including in the lung and the liver . Additionally, it was demonstrated that TSWV induced a strong immune response in its insect vector Frankliniella occidentalis  and that oral administration of Cowpea severe mosaic virus, Alfalfa mosaic virus and chimeric plant virus particles induced a durable and systemic immune response in mice , . In addition, Zhang et al. identified that the vast majority of the viral sequences recovered from human feces corresponded to plant pathogenic RNA viruses . There, the most abundant viral sequences isolated were from Pepper mild mottle virus (PMMoV), with up to 109 virions per gram of dry weight fecal matter, while other tobamoviruses as Paprika mild mottle virus, Tomato mosaic virus, and Tobacco mild green mosaic virus were also detected. In another study, high-throughput sequencing also identified PMMoV RNA and other plant virus-derived sequences in 3 of the 4 fecal specimens collected from adult patients during norovirus outbreaks . Very recently, we confirmed that a high PMMoV load, likely originating from food items, may be present in the human stools, and we found that PMMoV may be associated with a specific immune response and clinical symptoms, possibly imputable to spicy food, including fever, abdominal pains, and pruritus .
Until now, a major issue that precluded considering plant viruses as potential pathogens in humans was that they could not enter and replicate in vertebrate cells. A few aforementioned studies questioned the certainty of this paradigm , . Moreover, mechanisms other than replication-induced pathogenicity may exist. For example, an alternative process may consist of deregulations through the micro-RNA (miRNA) regulatory pathway, which has been involved in pathogenicity in plants and in humans. Indeed, Bazzini et al. found that viruses that produce the most severe symptoms on tobacco (TMV and Tomato mosaic virus) altered miRNA accumulation to a greater extent than did viruses that produce mild symptoms (Tobacco etch virus and Potato virus Y) . Additionally, the silencing suppressor activity of the TMV 126-kDa small replicase subunit is correlated with increased virus induced symptoms in tobacco  and it has been described that some phytoviruses RNA-silencing suppressors including the P38 protein of Turnip crinkle virus (TCV), the P19 protein of Tomato bushy stunt virus (TBSV) and the P15 protein of Peanut clump virus (PCV) were functional as silencing suppressors in human Hela cells  Furthermore, many human cancers appear to be induced by miRNA deregulation . Therefore, the issue of interactions between plant viruses and the human body may be addressed by considering non-canonical mechanisms of diseases in vertebrate animals.
In summary, our findings and previous works suggest that the boundaries between Plantae and Vertebrata viruses may be less strict than currently accepted and they prompt a reevaluation of the potential pathogenicity of plant viruses for animals with modern microbiological tools. The role of these virions may be elucidated by analyzing the reprogramming of human cells inoculated by TMV.
Materials and Methods
TMV Production and Purification from Tobacco Plants
Nicotiana tabacum Samsun plants were infected with the tmj strain of TMV by mechanical inoculation. Dried infected leaf tissue kept over CaCl2 were then crushed in phosphate buffer 0.01 M Na2HPO4-KH2PO4 pH 7.2 (buffer no. 1) using 1 g of leaves per 4 ml of buffer, with carborundum (75 mg/ml) and activated charcoal (75 mg/ml). Three leaves per plant were inoculated mechanically with a gloved finger before being rinsed with water. Two weeks later, young leaves with signs were collected and fresh leaves were ground into phosphate buffer no. 2 (0.5 M Na2HPO4-KH2PO4 pH 7.2) using 1 g of fresh leaves per 3 ml of buffer; 1% 2-mercapto-ethanol was added just before grinding. After homogenization, 8% (v/v) n-butanol was added to the extract and was stirred for 15 min before centrifugation at 10,000 g for 30 min at 10°C. The supernatant was filtered on cheese-cloth tissue then stirred for 15 min with polyethylene glycol (PEG) 6000 4% (w/v). After a centrifugation step at 10,000 g for 15 min at 10°C, the pellet was diluted into 10 ml of buffer no. 1. This solution was centrifuged at 10,000 g for 15 min at 10°C, and the supernatant was complemented with PEG 6000 4% (w/v) and NaCl 4% (w/v), before stirring for 15 min and centrifugating at 10,000 g for 15 min at 10°C. The pellet was diluted into 1–2 ml of buffer no. 1 and then centrifuged at 10,000 g for 15 min at 10°C. Thereafter, the supernatant was ultracentrifuged for 16 h at 35,000 rpm (Beckman 70.1TI rotor) in a cesium chloride gradient (0.505 g/ml). The whitish band corresponding to the virus was collected with a needle and a syringe, then diluted into buffer no. 1 and ultracentrifuged at 38,000 rpm (Beckman 50.2Ti rotor) for 2.5 h at 10°C. Finally, the pellet containing the purified virus was resuspended into 500 µl of buffer no. 1. The viral titer was obtained by spectrometry using an extinction coefficient at 260 nm of 3 (Nanodrop 1000 Spectrophotometer).
Mouse Inoculation with TMV
Mice were anesthetized by intra-peritoneal injection with ketamine/xylazine (10 µl per gram of mouse). Next, they were inoculated intratracheally with 50 µl of 1010–1011 purified TMV particles, or water for control mice. TMV-inoculated mice and control (water-inoculated) mice were sacrificed at days 1, 2, 3, 7, 12 and 14 post-inoculation. The experiment of mouse inoculation with TMV was realized twice. In experiment 1, three TMV-inoculated and two water-inoculated mice were sacrificed at day 1, 3, 7 and 14 after inoculation. In experiment 2, three TMV-inoculated mice were sacrificed at day 2 and 7, two TMV-inoculated mice were sacrificed at day 12 and one was sacrificed at day 14. One water-inoculated mouse was sacrificed at day 2, 7 and 14. Bronchoalveolar lavages (BAL) were obtained in experiment 2 by injection of sterile physiological salt solution in the respiratory tract of mice followed by aspiration. To obtain macrophages, BAL were centrifuged at 300 g for 10 min at 4°C, the cellular pellet was washed in 1 ml RPMI plus 10% FBS and was incubated at 37°C for 3 h in 1 ml of RPMI plus 10% FBS. Macrophages were collected from the wells in 200 µl of PBS (1X). In addition, lungs were collected from the sacrificed mice.
Histological and Immunohistological Analysis of TMV-infected Mouse Lung Tissues
For each mouse, lungs were removed, fixed with neutral buffered formalin (4%), and embedded in paraffin. Serial sections (3 µm) of these specimens were obtained for hematoxylin-eosin and immunohistochemical investigations. Immunohistochemical analyses were performed with a polyclonal rabbit anti-TMV antibody used at a 1∶500 dilution. The immunohistological procedure, in which an immunoperoxidase LSAB K 680 kit (Dako, Trappes, France) was used, has been described elsewhere .
Anti-TMV Antibodies Detection by ELISA
In a first manipulation, anti-TMV IgG/IgM antibodies were tested in serum samples from 10 TMV-inoculated mice and 5 water-inoculated mice immediately before the intratracheal inoculation and 7 and 14 days after inoculation. In a second manipulation, anti-TMV antibodies were tested in the serum of 3 TMV-inoculated and 3 control mice sacrificed 7 and 14 days after inoculation. ELISA Nunc Maxisorp plates were coated with 100 µl of purified TMV (1 µg per well) and incubated at 4°C overnight. Thereafter, they were washed with PBS Tween 0.1% and agitated for 30 min after the addition of 200 µl of PBS with 5% milk in each well, and then the plates were washed with PBS Tween 0.1%. The serum samples were diluted to 1∶100 in PBS with 3% dried milk and 0.1% Tween. Then, 100 µl of diluted samples were added to each well and were incubated for 1 h at room temperature. The plates were washed with PBS Tween 0.1%, and then 100 µl of biotinylated anti-mouse IgG/IgM specific antibody diluted to 1∶5000 in PBS-milk 3%-Tween 0.1% were added in each well. The plates were agitated for 1 h. Thereafter, the wells were washed with PBS Tween 0.1%, and 100 µl of streptavidin HRPO conjugate CALTAG (BD Biosciences Pharmingen, Le pont de Claix, France) at 1∶10000 dilution in PBS-milk 3%-Tween 0.1% were deposited in each well. Next, the plates were washed with PBS Tween 0.1% and 200 µl of ortho-phenylenediamine was added per well. Finally, 10 min later, optical density was measured for each well at 492 nm.
Viral RNA Extraction from Lungs
Pieces of lung were crushed in 800 µl of buffer no. 1 using a small pestle directly in the 1.5 ml microfuge tube. Then, RNA was extracted from 200 µl of the homogenates using the EZ1 virus Mini kit (version 2.0) on the BioRobot EZ1 workstation (Qiagen, Courtaboeuf, France). RNA samples were eluted in 60 µl final volume and stored at −80°C until processing. The same procedure was used for viral RNA extraction from BAL macrophages.
TMV RNA Detection by Real-time RT-PCR
From mouse lungs, TMV RNA was detected and quantified using two systems of real-time reverse transcription (RT)-PCR, one targeting a region that corresponds to a fragment of the capsid gene and the other targeting the replicase gene (Table 1), with the SuperScript III Platinum One-Step Quantitative RT-PCR System (Invitrogen Life Technologies, Carlsbad, Calif., USA) on a Mx3000P thermocycler (Stratagene, La Jolla, CA 92037 USA) under the following conditions: 50°C for 30 min for RT, 95°C for 2 min for initial denaturation and 45 cycles including 95°C for 30 sec and 60°C for 1 minute. For each 25 µl reaction, the PCR mix contained 12.5 µl of reaction buffer, 0.75 µl of each primer (10 pmol/µl), 0.5 µl of probe, 0.5 µl of SuperScript III/RT Platinum Taq mix, 5 µl H2O and 5 µl of RNA extract sample. From the mouse BAL macrophages, TMV RNA was detected and quantified using the capsid gene system.
TMV RNA Population Sequencing
TMV RNA sequences corresponding to a fragment of the helicase or the movement protein encoding gene (Table 1) were obtained by RT-PCR amplification using the SuperScript One-Step RT-PCR System (Invitrogen Life Technologies). For RT-PCR amplification, ten µl of extracted viral RNA were added to 40 µl reaction solution containing 1 µl (10 pmol/µl) of each primer, 25 µl of reaction buffer, 12 µl of water and 1 µl of RT/Platinum Taq mix. The RT-PCR reactions were conducted under the following conditions: 45°C for 30 min for RT, 94°C for 2 min for initial denaturation, followed by 40 cycles including denaturation at 94°C for 30 s, annealing at 55°C for 45 s, elongation at 72°C for 2 min, then a final elongation step at 72°C for 10 min. PCR products were purified with Sephadex G-50 Superfine on MAHVN 4550 plates (Millipore, Molsheim, France) then sequenced by using the amplification PCR primers and the Big Dye Terminator cycle sequencing kit version 1.1 on the ABI Prism 3130 genetic analyzer (Applied Biosystems, Branchburg, NJ, USA).
Test of Infectivity with TMV
Lung samples were crushed in 1 ml of buffer no. 1. Then, 200 µl of this homogenate was mixed with carborundum and mechanically inoculated on Nicotiana tabacum Xanthi, which is a hypersensitive host for TMV, and on Nicotiana benthamiana, which is a susceptible host for TMV. In the presence of infectious TMV in the tested sample, local necrotic lesions appears on N. tabacum Xanthi one week after the mechanical inoculation and mosaic appears on the susceptible hosts after an additional week.
TMV Immunofluorescence in Bone Marrow-Derived Macrophages (BMDM) after TMV Inoculation
A total of 105 adherent BMDM cells per well on glass slides were inoculated with 1010 TMV particles. Four hours, one day, three days, 7 days and 14 days after inoculation, BMDM cells were fixed in 250 µl of 3% paraformaldehyde solution for 20 min at room temperature and were then washed with PBS 1X. Thereafter, the cells were incubated for 15 min with 250 µl of ammonium chloride NH4Cl (0.5 M) and were washed three times with PBS 1X. Non-inoculated cells were used as controls. A drop of 40 µl of PBS 1X solution containing 10% FBS and 0.1% saponin was applied, and the glass slides, cells side up, were incubated for 20 min in a humid chamber,. Then, a 40 µl drop of mouse monoclonal anti-TMV antibody, produced as previously described  and diluted 1∶25 in a solution of PBS containing 5% FCS and 0.1% saponin (solution A) was applied to the slides. These slides were incubated for 20 min in the dark in the humid chamber, followed by thorough rinsing in PBS 1X with 0.1% saponin. Another drop was applied containing secondary goat anti-mouse antibody (555 nm) diluted 1∶500 and phallacidin (actin marker, 488 nm) diluted at 1∶200 in the solution A. The slides were incubated for 20 min in the dark chamber, thoroughly rinsed in PBS 1X with 0.1% saponin, and then a drop of DAPI (diluted 1∶10000 in PBS 1X) was applied for 10 min. The slides were washed in PBS 1X with 1% saponin and then in distilled water, before being glued with 5 µl of Moviol on microscopy glass slides. The slides were dried overnight before observation with confocal microscopy (Leica TCS SP5) with sections of 0.15 µm, oil immersion objective of 63X, a numerical aperture of 1.4, and a digital zoom of 2 for an image of 1024×1024 pixels.
TMV RNA Detection in Bone Marrow-Derived Macrophages (BMDM) after Inoculation with TMV
A total of 105 bone marrow-derived macrophages (BMDM) per well were incubated overnight at 37°C in Dulbecco’s Modified Eagle’s Medium (DMEM) plus 1% glutamine, 1% penicillin-streptavidin and 10% FBS. Each well was inoculated with 20 µl of solutions containing 107, 109, or 1011 TMV particles. Non-inoculated cells were used as controls. Four hours after the inoculation, culture media were discarded and the cells were washed three times with culture medium, then 1 ml of culture medium was added to cells for incubation. The culture media and BMDM cells were collected at day 0 (4 h), 3, 6, 9, 12 and 15 after TMV inoculation. Before collection, cells were washed twice with culture medium and twice with PBS 1X before being recovered in 200 µl of PBS 1X by mechanical scraping with a tip. The culture media and BMDM cells were used for TMV detection by real-time RT-PCR.
Statistical analysis was performed with EpiInfo version 3.51, centers for Disease Control and prevention (CDP) Atlanta (GA,USA). Means values were compared by using either ANOVA test or Krustal-Wallis test according to the homogeneity of the variance measured by the Bartlett’s test. Differences were considered statistically significant if p value <0.05.
This study has been approved by our institutional ethics committee for animal experiment of Aix-Marseille University (Comité d’Ethique de Marseille; Comité National de Réflexion Ethique sur l’Expérimentation Animale, no. 14), according to the guidelines of the ethics committee for animal treatment. (Agreement reference number 16-21052012).
We would like to thank Audrey Borg, Audrey Averna, and Catherine Wipf-Scheibel for their technical assistance.
Conceived and designed the experiments: DR PC JLM EG H. Lecoq. Performed the experiments: FB AB CN KA AF TN H. Lepidi. Analyzed the data: FB PC H. Lepidi EG JLM H. Lecoq. Contributed reagents/materials/analysis tools: FB AB CN KA AF TN H. Lepidi EG. Wrote the paper: FB PC H. Lepidi EG JLM DR.
- 1. Jones RA (2009) Plant virus emergence and evolution: origins, new encounter scenarios, factors driving emergence, effects of changing world conditions, and prospects for control. Virus Res 141: 113–130. S0168-1702(08)00434-6 [pii];10.1016/j.virusres.2008.07.028 [doi].
- 2. Pascual DW (2007) Vaccines are for dinner. Proc Natl Acad Sci U S A 104: 10757–10758. 0704516104 [pii];10.1073/pnas.0704516104 [doi].
- 3. Nochi T, Takagi H, Yuki Y, Yang L, Masumura T, et al. (2007) Rice-based mucosal vaccine as a global strategy for cold-chain- and needle-free vaccination. Proc Natl Acad Sci U S A 104: 10986–10991. 0703766104 [pii];10.1073/pnas.0703766104 [doi].
- 4. Rogers SO, Starmer WT, Castello JD (2004) Recycling of pathogenic microbes through survival in ice. Med Hypotheses 63: 773.
- 5. Bothwell PW (1960) Lung cancer and tobacco mosaic virus. Lancet 1.
- 6. Wahyuni WS, Hanapi M, Hartana I (2008) The Presence of tobacco mosaic virus in the compost extract of Cigar Tobacco Debris. Journal of Biosciences 15: 118–22.17.
- 7. Harrison BD, Wilson TM (1999) Milestones in the research on tobacco mosaic virus. Philos Trans R Soc Lond B Biol Sci 354: 521–529. 10.1098/rstb.1999.0403 [doi].
- 8. Adams MJ, Antoniw JF, Kreuze J (2009) Virgaviridae: a new family of rod-shaped plant viruses. Arch Virol 154: 1967–1972. 10.1007/s00705-009-0506-6 [doi].
- 9. Scholthof KB, Adkins S, Czosnek H, Palukaitis P, Jacquot E, et al. (2011) Top 10 plant viruses in molecular plant pathology. Mol Plant Pathol 12: 938–954.
- 10. Karasev AV, Foulke S, Wellens C, Rich A, Shon KJ, et al. (2005) Plant based HIV-1 vaccine candidate: Tat protein produced in spinach. Vaccine 23: 1875–1880. S0264-410X(04)00847-3 [pii];10.1016/j.vaccine.2004.11.021 [doi].
- 11. McCormick AA, Corbo TA, Wykoff-Clary S, Palmer KE, Pogue GP (2006) Chemical conjugate TMV-peptide bivalent fusion vaccines improve cellular immunity and tumor protection. Bioconjug Chem 17: 1330–1338. 10.1021/bc060124m [doi].
- 12. Staczek J, Bendahmane M, Gilleland LB, Beachy RN, Gilleland HE Jr (2000) Immunization with a chimeric tobacco mosaic virus containing an epitope of outer membrane protein F of Pseudomonas aeruginosa provides protection against challenge with P. aeruginosa. Vaccine 18: 2266–2274. S0264-410X(99)00571-X [pii].
- 13. Fujiyama K, Saejung W, Yanagihara I, Nakado J, Misaki R, et al. (2006) In Planta production of immunogenic poliovirus peptide using tobacco mosaic virus-based vector system. J Biosci Bioeng 101: 398–402. S1389-1723(06)70600-4 [pii];10.1263/jbb.101.398 [doi].
- 14. Knowland J (1974) Protein synthesis directed by the RNA from a plant virus in a normal animal cell. Genetics 78: 383–394.
- 15. Dimitriadis GJ, Georgatsos JG (1975) Synthesis of tobacco mosaic virus coat protein following migration of viral RNA into isolated mouse liver mitochondria. Nucleic Acids Res 2: 1719–1726.
- 16. Salomon R, Bar-Joseph M (1982) Translational competition between related virus RNA species in cell-free systems. J Gen Virol 62 (Pt 2): 343–347.
- 17. Li L, Wang L, Xiao R, Zhu G, Li Y, et al. (2012) The invasion of tobacco mosaic virus RNA induces endoplasmic reticulum stress-related autophagy in HeLa cells. Biosci Rep 32: 171–186. BSR20110069 [pii];10.1042/BSR20110069 [doi].
- 18. Erickson JO, Armen DM, Libby RL (1953) The persistence of antigen in the mouse. J Immunol 71: 30–37.
- 19. Erickson JO, Hensley TJ, Fields M, Libby RL (1957) Intracellular localization of tobacco mosaic virus in mouse liver. J Immunol 78: 95–103.
- 20. Katsilambros L (1960) Tobacco mosaic virus and lung cancer. Lancet 2.
- 21. LeClair RA (1967) Recovery of culturable tobacco mosaic virus from sputum and thoracentesis fluids obtained from cigarette smokers with a history of pulmonary disease. Am Rev Respir Dis 95: 510.
- 22. Zhang T, Breitbart M, Lee WH, Run JQ, Wei CL, et al. (2006) RNA viral community in human feces: prevalence of plant pathogenic viruses. PLoS Biol 4: e3. 05-PLBI-RA-0736R2 [pii];10.1371/journal.pbio.0040003 [doi].
- 23. Nakamura S, Yang CS, Sakon N, Ueda M, Tougan T, et al. (2009) Direct metagenomic detection of viral pathogens in nasal and fecal specimens using an unbiased high-throughput sequencing approach. PLoS One 4: e4219. 10.1371/journal.pone.0004219 [doi].
- 24. Wetter C (1975) [Tobacco mosaic virus and para-tobacco mosaic virus in cigarettes]. Naturwissenschaften 62: 533.
- 25. Balique F, Colson P, Raoult D (2012) Tobacco mosaic virus in cigarettes and saliva of smokers. J Clin Virol. S1386–6532(12)00316-2 [pii];10.1016/j.jcv.2012.08.012 [doi].
- 26. Bousbia S, Papazian L, La Scola B, Raoult D (2010) Detection of plant DNA in the bronchoalveolar lavage of patients with ventilator-associated pneumonia. PLoS One 5: e11298. 10.1371/journal.pone.0011298 [doi].
- 27. Wales SQ, Smith CC, Wachsman M, Calton G, Aurelian L (2004) Performance and use of a ribonucleotide reductase herpes simplex virus type-specific serological assay. Clin Diagn Lab Immunol 11: 42–49.
- 28. Cao L, Chen DL, Lee C, Chan CM, Chan KM, et al. (1998) Detection of specific antibodies to an antigenic mannoprotein for diagnosis of Penicillium marneffei penicilliosis. J Clin Microbiol 36: 3028–3031.
- 29. Kitajima EW, Gamez R (1983) Electron microscopy of maize rayado fino virus in the internal organs of its leafhopper vector. Intervirology 19: 129–134.
- 30. Nault LR (1997) Arthropod transmission of plant viruses: a new synthesis. Annals of the Entomoogical Society of America 90: 521–541.
- 31. Guo JY, Ye GY, Dong SZ, Liu SS (2010) An invasive whitefly feeding on a virus-infected plant increased its egg production and realized fecundity. PLoS One 5: e11713. 10.1371/journal.pone.0011713 [doi].
- 32. Wijkamp I, Jan Van L, Kormelink R, Goldbach R, Peters D (1993) Multiplication of tomato spotted wilt virus in its insect vector, Frankliniella occidentalis. J Gen Virol 74 (Pt 3): 341–349.
- 33. Rubinstein G, Czosnek H (1997) Long-term association of tomato yellow leaf curl virus with its whitefly vector Bemisia tabaci: effect on the insect transmission capacity, longevity and fecundity. J Gen Virol 78 (Pt 10): 2683–2689.
- 34. de Medeiros RB, Figueiredo J, Resende RO, De Avila AC (2005) Expression of a viral polymerase-bound host factor turns human cell lines permissive to a plant- and insect-infecting virus. Proc Natl Acad Sci U S A 102: 1175–1180. 0406668102 [pii];10.1073/pnas.0406668102 [doi].
- 35. Koudelka KJ, Destito G, Plummer EM, Trauger SA, Siuzdak G, et al. (2009) Endothelial targeting of cowpea mosaic virus (CPMV) via surface vimentin. PLoS Pathog 5: e1000417. 10.1371/journal.ppat.1000417 [doi].
- 36. Rae CS, Khor IW, Wang Q, Destito G, Gonzalez MJ, et al. (2005) Systemic trafficking of plant virus nanoparticles in mice via the oral route. Virology 343: 224–235. S0042-6822(05)00468-X [pii];10.1016/j.virol.2005.08.017 [doi].
- 37. Medeiros RB, Resende RO, De Avila AC (2004) The plant virus Tomato Spotted Wilt Tospovirus activates the immune system of its main insect vector, Frankliniella occidentalis. J Virol 78: 4976–4982.
- 38. Modelska A, Dietzschold B, Sleysh N, Fu ZF, Steplewski K, et al. (1998) Immunization against rabies with plant-derived antigen. Proc Natl Acad Sci U S A 95: 2481–2485.
- 39. Brennan FR, Bellaby T, Helliwell SM, Jones TD, Kamstrup S, et al. (1999) Chimeric plant virus particles administered nasally or orally induce systemic and mucosal immune responses in mice. J Virol 73: 930–938.
- 40. Colson P, Richet H, Desnues C, Balique F, Moal V, et al. (2010) Pepper mild mottle virus, a plant virus associated with specific immune responses, Fever, abdominal pains, and pruritus in humans. PLoS One 5: e10041. 10.1371/journal.pone.0010041 [doi].
- 41. Bazzini AA, Hopp HE, Beachy RN, Asurmendi S (2007) Infection and coaccumulation of tobacco mosaic virus proteins alter microRNA levels, correlating with symptom and plant development. Proc Natl Acad Sci U S A 104: 12157–12162. 0705114104 [pii];10.1073/pnas.0705114104 [doi].
- 42. Vogler H, Akbergenov R, Shivaprasad PV, Dang V, Fasler M, et al. (2007) Modification of small RNAs associated with suppression of RNA silencing by tobamovirus replicase protein. J Virol 81: 10379–10388. JVI.00727-07 [pii];10.1128/JVI.00727-07 [doi].
- 43. Dunoyer P, Lecellier CH, Parizotto EA, Himber C, Voinnet O (2004) Probing the microRNA and small interfering RNA pathways with virus-encoded suppressors of RNA silencing. Plant Cell 16: 1235–1250. 10.1105/tpc.020719 [doi];tpc.020719 [pii].
- 44. Garzon R, Calin GA, Croce CM (2009) MicroRNAs in Cancer. Annu Rev Med 60: 167–179. 10.1146/annurev.med.59.053006.104707 [doi].
- 45. La Scola B, Lepidi H, Raoult D (1997) Pathologic changes during acute Q fever: influence of the route of infection and inoculum size in infected guinea pigs. Infect Immun 65: 2443–2447.